NCT02147093 is a NA clinical trial of Test (multi-focal) in Presbyopia Correction, sponsored by Johnson & Johnson Vision Care, Inc..

Who is sponsoring NCT02147093?

NCT02147093 is sponsored by Johnson & Johnson Vision Care, Inc..

What drugs are being tested in NCT02147093?

Interventions in NCT02147093: Test (multi-focal), Control (Sphere).

What condition does NCT02147093 study?

NCT02147093 studies Presbyopia Correction.

Is NCT02147093 still recruiting?

NCT02147093 is currently completed. Last updated 19 June 2018.

Are results published for NCT02147093?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2018-06-19 · How we verify

NCT02147093

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CLARITI (TM) 1-Day Multifocal Contact Lenses Performance and Acceptance Evaluation

Completed NA Results posted Last updated 19 June 2018

What this trial tests

NA trial testing Test (multi-focal) in Presbyopia Correction in 41 participants. Completed in 1 August 2014.

Timeline

1 May 2014

Primary endpoint
1 August 2014

1 August 2014

Quick facts

Lead sponsor	Johnson & Johnson Vision Care, Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	treatment
Enrollment	41
Start date	1 May 2014
Primary completion	1 August 2014
Estimated completion	1 August 2014
Sites	1 location across United Kingdom

Drugs / interventions tested

Test (multi-focal)
Control (Sphere)

Conditions studied

Presbyopia Correction — all drugs for Presbyopia Correction →

Sponsor

Johnson & Johnson Vision Care, Inc. — full company profile →

Who can join

45 and older, any sex, with Presbyopia Correction. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Distance LogMAR Visual Acuity Primary · 7 days post wear

Distance time controlled LogMAR (Logarithm of the Minimum Angle of Resolution) Visual Acuity was carried out binocularly, at 4m (meter) under 250 cd/m\^2 and 2.5 cd/m\^2 (candela per square meter) luminance. The test was presented under the two conditions; High luminance (250 cd/m\^2) High Contrast (90%) \& Low Contrast (10%) and Low Luminance (2.5 cd/m\^2) High Contrast (90%)

High Contrast-Distance-Standard High Luminance

Group	Value	95% CI
Control (Filcon II 3-sphere)	-0.466	± 0.9995
Test (Filcon II 3-multi-focal)	-0.972	± 1.0104

Low Contrast-Distance-Standard High Luminance

Group	Value	95% CI
Control (Filcon II 3-sphere)	-2.842	± 1.6850
Test (Filcon II 3-multi-focal)	-3.768	± 1.8023

High Contrast-Distance-Standard Low Luminance

Group	Value	95% CI
Control (Filcon II 3-sphere)	-2.834	± 1.0042
Test (Filcon II 3-multi-focal)	-3.700	± 0.8939

Near LogMAR Visual Acuity Primary · 7 days post wear

Near time controlled LogMAR Visual Acuity was carried out binocularly, at 4cm under 250 cd/m\^2 and 50 cd/m\^2 luminance. The test was presented on under the two conditions; High Luminance (250cd/m\^2) High Contrast (90%) \& Low Contrast (10%) and Low Luminance (50cd/m\^2) High Contrast (90%)

High Contrast-Near-Standard High Luminance

Group	Value	95% CI
Control (Filcon II 3-sphere)	-1.455	± 0.6309
Test (Filcon II 3-multi-focal)	-2.545	± 1.1240

Low Contrast-Near-Standard High Luminance

Group	Value	95% CI
Control (Filcon II 3-sphere)	-2.151	± 1.0221
Test (Filcon II 3-multi-focal)	-3.820	± 1.4124

High Contrast-Near-Standard Low Luminance

Group	Value	95% CI
Control (Filcon II 3-sphere)	-1.878	± 1.0546
Test (Filcon II 3-multi-focal)	-3.441	± 1.3941

Sponsor's own description

A comparative evaluation of a newly marketed multifocal contact lens with a single vision contact lens when used with near vision spectacles. The evaluation was to quantify the difference between the two test corrections.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Presbyopia Correction

Currently open trials in the same condition.

NCT06702020 — VIS Opti-K Vision Improvement for Presbyopes · active not recruiting

Other Johnson & Johnson Vision Care, Inc. trials

Trials by the same sponsor.

NCT07443215 — Evaluation of Effect of Scatter on Visual Performance · NA · recruiting
NCT07174596 — Evaluation of Approved Contact Lenses · NA · completed
NCT07076160 — Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses · NA · completed
NCT06967129 — Evaluation of Daily Disposable Toric Soft Lenses Manufactured With an Alternative Hydration Process · NA · completed
NCT06864858 — Clinical Evaluation of Two Cosmetic Contact Lenses · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02147093 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johnson & Johnson Vision Care, Inc.
Last refreshed: 19 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02147093.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing